Serum pepsinogen can predict response to H2-receptor antagonist in patients with functional dyspepsia

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 10, 2002, Pages 1805-1809

  Yoshikawa, I ^a   Murata, I ^a   Kume, K ^a   Kanagawa, K ^a   Hirohata, Y ^a   Nakamura, H ^a   Otsuki, M ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN; HISTAMINE H2 RECEPTOR ANTAGONIST; PEPSINOGEN; PEPSINOGEN II; ROXATIDINE; ROXATIDINE ACETATE; STOMACH SECRETION INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; DYSPEPSIA; ENZYME BLOOD LEVEL; FEMALE; HUMAN; MALE; MEASUREMENT; PRIORITY JOURNAL; PROGNOSIS; SEROLOGY; STOMACH ACID SECRETION;

ADULT; AGED; ANTI-ULCER AGENTS; BIOLOGICAL MARKERS; DYSPEPSIA; FEMALE; GASTRINS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PEPSINOGEN A; PEPSINOGEN C; PIPERIDINES; TREATMENT OUTCOME;

EID: 0036791264     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01352.x     Document Type: Article

References (24)

1. Talley NJ, Zinsmeister AR, Schleck CD, et al. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102: 1259-68.
2. Jones R, Lydeard S. Prevalence of symptoms of dyspepsia in the community. Lancet 1989; 1: 47-51.
3. Talley NJ. Functional dyspepsia - should treatment be targeted on disturbed physiology? Aliment Pharmacol Ther 1995; 9: 107-15.
4. Fischer RS, Parkman HP. Management of nonulcer dyspepsia. N Engl J Med 1998; 339: 1376-81.
5. Nyrén O, Adami H-O, Bates S, et al. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986; 314: 339-43.
6. Farup PG, Osnes WM, Ulshagen K. Ranitidine effectively relieves symptoms in a subset of patients with functional dyspepsia. Scand J Gastroenterol 1997; 32: 755-9.
7. Samloff IM, Varis K, Ihamaki T, et al. Relationship among serum pepsinogen I, serum pepsinogen II and gastric mucosal histology: a study in relatives of patients with pernicious anemia. Gastroenterology 1982; 83: 204-9.
8. Samloff IM, Secrist DM, Passaro E. A study of the relationship between serum group 1 pepsinogen levels and gastric acid secretion. Gastroenterology 1975; 69: 1196-200.
9. Kinoshita Y, Yamashita Y, Kitajima N, et al. Correlation between serum pepsinogen concentration and gastric acidity measured by 24 h pH monitoring. J Gastroenterol Hepatol 1995; 10: 152-7.
10. Samsom M, Verhagen MA, vanBerge Henegouwen GP, et al. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology 1999; 116: 515-20.
11. el-Omar E, Penman I, Ardill JE, et al. A substantial portion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut 1995; 36: 534-8.
12. Yanaka Y, Mine K, Nakai Y, et al. Serum pepsinogen I concentrations in peptic ulcer patients in relation to ulcer location and stage. Gut 1991; 32: 849-52.
13. Jebbink HJ, Smout AJ, van Berge-Hanegouwen GP. Pathophysiology and treatment of functional dyspepsia. Scand J Gastroenterol Suppl 1993; 200: 8-14.
14. Mearin F, Cucala M, Azpiroz F, et al. The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology 1991; 101: 999-1006.
15. Pantoflickova D, Koelz HR, Blum AL. Helicobacter pylori and functional dyspepsia: a real causal link? Baillieres Clin Gastroenterol 1998; 12: 503-32.
16. Allescher HD, Bockenhoff A, Knapp G, et al. Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies. Scand J Gastroenterol 2001; 36: 934-41.
17. Chiba N, Bernard L, O'Brien BJ, et al. A Canadian physician survey of dyspepsia management. Can J Gastroenterol 1998; 12: 83-90.
18. Tally NJ, Stanghellini V, Heading RC, et al. Functional gastroduodenal disorders. Gut 1999; 45(Suppl. 2): II37-42.
19. Penston JG, Pounder RE. A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 1996; 10: 83-9.
20. Talley NJ, Boyce P, Jones M. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut 1998; 42: 690-5.
21. Malagelada J-R. Functional dyspepsia - insights on mechanisms and management strategies. Gastroenterol Clin North Am 1996; 25: 103-12.
22. Collen MJ, Loebenberg MJ. Basal gastric acid secretion in nonulcer dyspepsia with or without duodenitis. Dig Dis Sci 1989; 34: 246-50.
23. Tally NJ, McNeil D, Hayden A, et al. Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in non-ulcer dyspepsia. Gastroenterology 1986; 91: 149-56.
24. Johannessen T, Fjosne U, Kleveland M, et al. Cimetidine responders in non-ulcer dyspepsia. Scand J Gastroenterol 1988; 23: 327-36.